HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

P&G Outspends The Competition On Skin Care Advertising In 2004

This article was originally published in The Rose Sheet

Executive Summary

Procter & Gamble allocated over $161.5 mil. to media campaigns backing its skin care brands, outspending both mass market competitors and prestige beauty companies in the segment in 2004, according to measured media expenditures tracked by TNS Media Intelligence

You may also be interested in...



P&G Reveals Thirst For Spending On Olay Quench Ads In 2005

Procter & Gamble backed the rollout of Olay Quench body lotions with approximately $44.6 mil. in advertising spend in the first three quarters of FY 2005, according to data from TNS Media Intelligence, which tracks 18 media sources, including network and cable TV, magazines, newspapers and radio

P&G Reveals Thirst For Spending On Olay Quench Ads In 2005

Procter & Gamble backed the rollout of Olay Quench body lotions with approximately $44.6 mil. in advertising spend in the first three quarters of FY 2005, according to data from TNS Media Intelligence, which tracks 18 media sources, including network and cable TV, magazines, newspapers and radio

Olay Daily Facials Clarity Targets Women With Combination Skin

Procter & Gamble will introduce Olay Daily Facials Clarity in February targeted to women with combination skin and positioned to control surface oil without leaving skin dry and irritated, according to the company

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS013053

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel